These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 19647174)
1. Comparison of 18F-FDG, 18F-FET and 18F-FLT for differentiation between tumor and inflammation in rats. Lee TS; Ahn SH; Moon BS; Chun KS; Kang JH; Cheon GJ; Choi CW; Lim SM Nucl Med Biol; 2009 Aug; 36(6):681-6. PubMed ID: 19647174 [TBL] [Abstract][Full Text] [Related]
2. Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model. van Waarde A; Cobben DC; Suurmeijer AJ; Maas B; Vaalburg W; de Vries EF; Jager PL; Hoekstra HJ; Elsinga PH J Nucl Med; 2004 Apr; 45(4):695-700. PubMed ID: 15073267 [TBL] [Abstract][Full Text] [Related]
3. O-(2-[(18)F]Fluoroethyl)- L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes. Rau FC; Weber WA; Wester HJ; Herz M; Becker I; Krüger A; Schwaiger M; Senekowitsch-Schmidtke R Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1039-46. PubMed ID: 12173018 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model. Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506 [TBL] [Abstract][Full Text] [Related]
5. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts]. Liu X; Zhou NK; Zhang JM; Liang ZY; Zheng X Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377 [TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of FET and FDG for differentiating lung carcinoma from inflammation in mice. Chang CH; Wang HE; Wu SY; Fan KH; Tsai TH; Lee TW; Chang SR; Liu RS; Chen CF; Chen CH; Fu YK Anticancer Res; 2006; 26(2A):917-25. PubMed ID: 16619487 [TBL] [Abstract][Full Text] [Related]
7. Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model. Cheng Z; Wei R; Wu C; Qing H; Jiang X; Lu H; Chen S; Li X; Xu G; Ai H Nucl Med Commun; 2015 Sep; 36(9):914-21. PubMed ID: 25973694 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of 11C-methionine for differentiating tumors from granulomas in experimental rat models: a comparison with 18F-FDG and 18F-FLT. Zhao S; Kuge Y; Kohanawa M; Takahashi T; Zhao Y; Yi M; Kanegae K; Seki K; Tamaki N J Nucl Med; 2008 Jan; 49(1):135-41. PubMed ID: 18077525 [TBL] [Abstract][Full Text] [Related]
9. Comparison of [18F]-tracers in various experimental tumor models by PET imaging and identification of an early response biomarker for the novel microtubule stabilizer patupilone. Ebenhan T; Honer M; Ametamey SM; Schubiger PA; Becquet M; Ferretti S; Cannet C; Rausch M; McSheehy PM Mol Imaging Biol; 2009; 11(5):308-21. PubMed ID: 19462209 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of 3'-deoxy-3'-18F-fluorothymidine for monitoring tumor response to radiotherapy and photodynamic therapy in mice. Sugiyama M; Sakahara H; Sato K; Harada N; Fukumoto D; Kakiuchi T; Hirano T; Kohno E; Tsukada H J Nucl Med; 2004 Oct; 45(10):1754-8. PubMed ID: 15471845 [TBL] [Abstract][Full Text] [Related]
11. Monitoring response to radiotherapy in human squamous cell cancer bearing nude mice: comparison of 2'-deoxy-2'-[18F]fluoro-D-glucose (FDG) and 3'-[18F]fluoro-3'-deoxythymidine (FLT). Molthoff CF; Klabbers BM; Berkhof J; Felten JT; van Gelder M; Windhorst AD; Slotman BJ; Lammertsma AA Mol Imaging Biol; 2007; 9(6):340-7. PubMed ID: 17643202 [TBL] [Abstract][Full Text] [Related]
12. 18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer. Pauleit D; Zimmermann A; Stoffels G; Bauer D; Risse J; Flüss MO; Hamacher K; Coenen HH; Langen KJ J Nucl Med; 2006 Feb; 47(2):256-61. PubMed ID: 16455631 [TBL] [Abstract][Full Text] [Related]
13. [18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer. Been LB; Hoekstra HJ; Suurmeijer AJ; Jager PL; van der Laan BF; Elsinga PH Oral Oncol; 2009 Dec; 45(12):e211-5. PubMed ID: 19692292 [TBL] [Abstract][Full Text] [Related]
14. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975 [TBL] [Abstract][Full Text] [Related]
18. Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats. Bolcaen J; Lybaert K; Moerman L; Descamps B; Deblaere K; Boterberg T; Kalala JP; Van den Broecke C; De Vos F; Vanhove C; Goethals I PLoS One; 2016; 11(8):e0161845. PubMed ID: 27559736 [TBL] [Abstract][Full Text] [Related]